Draft:Zinaida Good
or multiple published secondary sources that:
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: In accordance with Wikipedia's Conflict of interest guideline, I disclose that I have a conflict of interest regarding the subject of this article. JonSalaz (talk) 22:18, 15 August 2026 (UTC)
Zina Good | |
|---|---|
 | |
| Occupation | Assistant Professor |
| Academic background | |
| Education | University of British Columbia Stanford University |
| Academic work | |
| Institutions | Stanford University |
Doctoral students | Jane Feng Sean Wang |
| Website | https://www.zinagoodlab.com/ |
Zinaida Good (known professionally as Dr. Zina Good) is an assistant professor at Stanford University's Department of Medicine. She currently holds appointments in the Division of Immunology and Rheumatology, and the Division of Computational Medicine at Stanford University.[1]Dr. Good's laboratory at Stanford utilizes artifical intelligence to guide genetic enginneering of immune cells to treat cancer and autoimmune diseases. [2]
Education and early career
Good received her B.S. and M.S. degrees in Microbiology & Immunology from the University of British Columbia, and her Ph.D. in Computational & Systems Immunology from Stanford University in 2018.[3] Dr. Good completed her thesis on Lymphocyte differentiation trajectories in human health and cancer under the mentorship of Sean Bendall and Garry P. Nolan.[4]
Research
Good's research uses machine learning models to analyze cancer patient responses to cellular therapies and genetically engineering T cells to enhance their ability to treat cancer.[5]
Awards and Honors
- MOONSHOTS // ONE Honorable Mention Award (MPI), Laude Institute (2026 – 2027)
- Stanford Center for Digital Health Grant (MPI), Stanford Center for Digital Health (2026 – 2027)
- NIH Program Project Grant Investigator (Project 2 Lead), National Institutes of Health (NCI P01) (2025 – 2030)
- NIH Multimodal AI Initiative Award (MPI), National Institutes of Health (OD OT2) (2025 – 2027)
- Weill Cancer Hub West Team PROMISE Investigator (Project 3 Lead), Weill Family Foundation (2025 – 2027)
- NIH Pathway to Independence Award, National Institutes of Health (NCI K99/R00) (2024 – 2027)
- ACS-SCI Institutional Research Grant Pilot Project, American Cancer Society (2024 – 2025)
- Kona Innovation Challenge Award (MPI), Parker Institute for Cancer Immunotherapy (2024 – 2025)
- AACR Woman in Cancer Research Scholar, American Association for Cancer Research (2024)
- Parker Bridge Fellow, Parker Institute for Cancer Immunotherapy (2023 – 2026)
- Arthur and Sandra Irving Fellow, Arthur and Sandra Irving Cancer Immunology Symposium (2022)
- NK and Irene Cheung Family Scholar, Keystone Symposia (2022)
- Stanford Cancer Institute Fellow, Stanford Cancer Institute (2020 – 2021)
- ASH Abstract Achievement Award, American Society of Hematology (2019)
- Parker Scholar, Parker Institute for Cancer Immunotherapy (2018 – 2020)
- Keystone Symposium Scholar, Keystone Symposia (2018)
- Featured Wikipedia Editor, Wikimedia Foundation (2013)
- Member of the DARPA Shredder Challenge Winning Team “All Your Shreds Are Belong to Us”, Defense Advanced Research Projects Agency (2011)
Personal life
References
- ^ "Zinaida Good, Ph.D. | Stanford Medicine". CAP Profiles. Retrieved 2026-08-15.
- ^ "Good Lab | T cell therapy | Stanford, CA, USA". Goodlab. Retrieved 2026-08-15.
- ^ "Zinaida Good, Ph.D.'s Profile | Stanford Profiles". profiles.stanford.edu. Retrieved 2026-08-15.
- ^ Good, Zinaida; Bendall, Sean; Nolan, Garry P.; Cleary, Michael L.; Plevritis, Sylvia; Wernig, Marius; Immunology, Stanford University Program in. "Lymphocyte differentiation trajectories in human health and cancer".
{{cite journal}}: Cite journal requires|journal=(help) - ^ "zinaida good - Search Results - PubMed". PubMed. Retrieved 2026-08-15.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
or multiple published secondary sources that:
- provide significant coverage: discuss the subject in detail, not just brief mentions or routine announcements;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the subject, such as interviews, press releases, the subject's own website, or sponsored content.
Please add references that meet these criteria. If none exist, the subject is not yet suitable for Wikipedia.